Reuters logo
BRIEF-Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​
November 29, 2017 / 12:57 PM / 16 days ago

BRIEF-Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​

Nov 29 (Reuters) - Nanovibronix Inc:

* NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS

* NANOVIBRONIX INC - ‍EXPECTS TO COMPLETE TRIAL FOR USE OF PAINSHIELD IN PATIENTS WITH TRIGEMINAL NEURALGIA IN Q1 OF 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below